Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates

Thrombosis Research

Volumn 104, Issue 1, 2001, Pages 15-28

  Li, Min ^a   Handa, Shunnosuke ^a   Ikeda, Yasuo ^b   Goto, Shinya ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

GP Ib ; GP IIb IIIa; Shear; Tetramethylpyrazine; Von Willebrand factor

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; PADGEM PROTEIN; TETRAMETHYLPYRAZINE; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HERBAL MEDICINE; HUMAN; PRIORITY JOURNAL; SHEAR RATE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; VISCOMETER;

BLOOD PLATELETS; BLOOD VISCOSITY; COLLAGEN; DRUGS, CHINESE HERBAL; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROTEIN BINDING; PYRAZINES; STRESS, MECHANICAL; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 0035479018     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00343-7     Document Type: Article

References (40)

1. Recent cardiovascular drugs from Chinese medicinal plants
2. Clinical study on tetramethylpyrazine in treating myocardial ischemia and reperfusion injury
3. Clinical study of naoxin sutong in the treatment of acute cerebral infarction
4. Antiplatelet structure-activity relationship of tetramethylpyrazine
5. Antithrombotic/antiplatelet activity of tetramethylpyrazine
6. Inhibition of shear-induced platelet aggregation by Chinese herbal medicine
7. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets
8. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
9. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor
10. Distinct mechanisms of platelet aggregation as a consequence of different shear flow conditions
11. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets
12. Distinct structural attributes regulating von Willebrand factor A1 domain interaction with platelet glycoprotein Ibalpha under flow
13. Coronary thrombosis. Effects of blood flow on the mechanism of thrombus formation
14. Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor
15. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress
16. Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation
17. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation
18. Platelet surface P-selectin molecules increased after exposing platelet to a high shear flow
19. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelet
20. Platelet dense bodies loaded with mepacrine study in chronic idiopathic thrombocytopenic purpura (ITP)
21. Epinephrine augments von Willebrand factor-dependent shear-induced platelet aggregation
22. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles
23. Abciximab not RGD peptide inhibits von Willebrand factor-dependent platelet activation under shear
24. Enhanced shear-induced von Willebrand factor binding to platelets in acute myocardial infarction
25. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation
26. A monoclonal antibody-based enzyme immunoassay for human GMP-140/P-selectin
27. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uremic syndrome
28. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain
29. Enhanced shear-induced platelet aggregation in acute myocardial infarction
30. Inhibitory effects of tetramethylpyrazine on platelets during cardiopulmonary bypass and arterial thrombus formation in dogs
31. Signaling across the platelet adhesion receptor glycoprotein Ib-IX induces alpha IIbbeta 3 activation both in platelets and a transfected Chinese hamster ovary cell system
32. Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3) using a reconstituted mammalian cell expression model
33. Synergistic effect of epinephrine and shearing on platelet activation
34. Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions
35. Analysis of platelet adhesion to a collagen-coated surface under flow conditions: The involvement of glycoprotein VI (GP VI) in the platelet adhesion
36. Involvement of activated integrin alpha2beta1 in the firm adhesion of platelets onto a surface of immobilized collagen under flow conditions
37. The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase
38. Ligustrazine-induced endothelium-dependent relaxation in pulmonary arteries via an NO-mediated and exogenous l-arginine-dependent mechanism
39. Pretreatment with tetramethylpyrazine increases the release of PGI2 and decreases TXA2 release in isolated rat heart
40. Tetramethylpyrazine, a Chinese drug, blocks coronary vasoconstriction by endothelin-1 and decreases plasma endothelin-1 levels in experimental animals